Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia

Leukemia and Lymphoma

Volumn 40, Issue 5-6, 2001, Pages 511-520

  Fleming, R V ^a   Kantarjian, H M ^a   Husni, R ^a   Rolston, K ^a   Lim, J ^a   Raad, I ^a   Pierce, S ^a   Cortes, J ^a   Estey, E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Abelcet; ABLC; AmBisome; Amphotericin B; Fungal infections; Leukemia

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BILIRUBIN; CORTICOSTEROID; DIPHENHYDRAMINE; HYDROCORTISONE; PARACETAMOL; PETHIDINE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERABILITY; FEVER; HEADACHE; HUMAN; LEUKEMIA; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MYCOSIS; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; RIGOR; SIDE EFFECT; TREATMENT FAILURE; VOMITING;

EID: 0035049295     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097650     Document Type: Article

References (23)

1. Fungal infection in acute leukemia
2. Fungal infections in hematologic neoplasms: Autopsy findings
3. Empiric therapy with amphotericin B in febrile granulocytopenic patients
4. Favorable outcome of invasive aspergillosis in patients with acute leukemia
5. Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response
6. Amphotericin B: Still the "gold standard" for antifungal therapy
7. Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients
8. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients
9. Early AmBisome in febrile neutropenia in patients with haematological disorders
10. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation
11. Amphotericin B lipid complex (Abelcet) in the treatment of invasive mycoses: The North American experience
12. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies
13. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS
14. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data
15. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-center experience of 133 episodes in 116 patients
16. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
17. Invasive aspergillosis during induction therapy for acute leukemia: Predisposing and prognostic factors
18. Lipid formulations of amphotericin B
19. Lipid formulations of amphotericin B: Recent progress and future directions
20. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin
21. Emergency-use amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis: Historical-control comparison with amphotericin B
22. Lipid formulations of amphotericin B: Less toxicity but at what economic cost?